In the Press

BRM receives one year Small Business Innovation Research grant.

Worcester Telegram & Gazette - April 4- 2006 -- Biomedical Research Models, Inc. has received a one year Small Business Innovation Research grant of $295,807 from the National Institute of Allergy and Infectious Disease for work on a vaccine against herpes simplex virus type 2, the company reported. The government health institute is also recommending that BRM receive an additional $287,298 next year for a second year of work on the vaccine. BRM is a privately held life science company. HSV-2 is the virus most often responsible for genital herpes. BRM's DNA vaccine and a follow-up booster immunization are designed to raise an immune response against disease-causing agents. The company plans to test the vaccine first in mice.